Erbulozole: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A detailed overview of the pharmaceutical compound Erbulozole}} | |||
== | ==Erbulozole== | ||
Erbulozole is a synthetic pharmaceutical compound that belongs to the class of [[azole]] antifungal agents. It is primarily used in the treatment of various fungal infections by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. | |||
Erbulozole | ==Mechanism of Action== | ||
Erbulozole functions by targeting the enzyme [[lanosterol 14_-demethylase]], which is crucial in the biosynthesis of [[ergosterol]]. By inhibiting this enzyme, Erbulozole disrupts the production of ergosterol, leading to increased membrane permeability and ultimately the death of the fungal cell. | |||
== | ==Pharmacokinetics== | ||
Erbulozole is administered orally and is well absorbed in the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys. The compound has a half-life of approximately 24 hours, allowing for once-daily dosing in most therapeutic regimens. | |||
Erbulozole is | ==Clinical Uses== | ||
Erbulozole is indicated for the treatment of a variety of fungal infections, including: | |||
* [[Candidiasis]] | |||
* [[Aspergillosis]] | |||
* [[Cryptococcosis]] | |||
== Side Effects == | ==Side Effects== | ||
Common side effects of Erbulozole include: | |||
* Nausea | |||
* Headache | |||
* Abdominal pain | |||
Serious side effects, though rare, may include liver toxicity and severe allergic reactions. | |||
== | ==Synthesis== | ||
The synthesis of Erbulozole involves several key steps, starting from basic organic compounds and proceeding through a series of chemical reactions to form the final azole structure. The process is depicted in the image below. | |||
[[File:Erbulozole_synthesis.png|thumb|right|300px|Schematic representation of the synthesis of Erbulozole.]] | |||
==Related pages== | |||
* [[Antifungal medication]] | * [[Antifungal medication]] | ||
* [[ | * [[Azole]] | ||
* [[ | * [[Ergosterol]] | ||
[[Category:Antifungal agents]] | |||
[[Category:Azoles]] | |||
Latest revision as of 12:03, 15 February 2025
A detailed overview of the pharmaceutical compound Erbulozole
Erbulozole[edit]
Erbulozole is a synthetic pharmaceutical compound that belongs to the class of azole antifungal agents. It is primarily used in the treatment of various fungal infections by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes.
Mechanism of Action[edit]
Erbulozole functions by targeting the enzyme lanosterol 14_-demethylase, which is crucial in the biosynthesis of ergosterol. By inhibiting this enzyme, Erbulozole disrupts the production of ergosterol, leading to increased membrane permeability and ultimately the death of the fungal cell.
Pharmacokinetics[edit]
Erbulozole is administered orally and is well absorbed in the gastrointestinal tract. It is metabolized in the liver and excreted primarily through the kidneys. The compound has a half-life of approximately 24 hours, allowing for once-daily dosing in most therapeutic regimens.
Clinical Uses[edit]
Erbulozole is indicated for the treatment of a variety of fungal infections, including:
Side Effects[edit]
Common side effects of Erbulozole include:
- Nausea
- Headache
- Abdominal pain
Serious side effects, though rare, may include liver toxicity and severe allergic reactions.
Synthesis[edit]
The synthesis of Erbulozole involves several key steps, starting from basic organic compounds and proceeding through a series of chemical reactions to form the final azole structure. The process is depicted in the image below.
